002412 汉森制药
已收盘 07-01 15:00:00
资讯
新帖
简况
6月15日汉森制药涨5.27%，东方量化成长灵活配置混合A基金重仓该股
证券之星 · 06-15
6月15日汉森制药涨5.27%，东方量化成长灵活配置混合A基金重仓该股
汉森制药（002412）披露参股公司减少注册资本暨关联交易公告，6月2日股价下跌0.29%
证券之星 · 06-02
汉森制药（002412）披露参股公司减少注册资本暨关联交易公告，6月2日股价下跌0.29%
汉森制药（002412）披露董事会完成换届选举及高级管理人员聘任公告，5月26日股价下跌2.07%
证券之星 · 05-26
汉森制药（002412）披露董事会完成换届选举及高级管理人员聘任公告，5月26日股价下跌2.07%
汉森制药(002412)4月30日股东户数3.23万户，较上期增加15.74%
证券之星 · 05-25
汉森制药(002412)4月30日股东户数3.23万户，较上期增加15.74%
股市必读：汉森制药(002412)股东户数3.23万户，较上期增加15.74%
证券之星 · 05-11
股市必读：汉森制药(002412)股东户数3.23万户，较上期增加15.74%
汉森制药：截至2026年4月30日，公司含信用账户合并股东名册的股东总数为
证券之星 · 05-08
汉森制药：截至2026年4月30日，公司含信用账户合并股东名册的股东总数为
每周股票复盘：汉森制药（002412）股东户数降10.72%，净利增241.17%
证券之星 · 05-03
每周股票复盘：汉森制药（002412）股东户数降10.72%，净利增241.17%
汉森制药：公司严格按照《企业会计准则》等有关规定，采用整个存续期的预期信用损失的金额计量减值损失
证券之星 · 04-30
汉森制药：公司严格按照《企业会计准则》等有关规定，采用整个存续期的预期信用损失的金额计量减值损失
汉森制药（002412）2026年一季报简析：净利润同比增长241.17%，盈利能力上升
证券之星 · 04-29
汉森制药（002412）2026年一季报简析：净利润同比增长241.17%，盈利能力上升
异动快报：汉森制药（002412）4月28日9点36分触及涨停板
证券之星 · 04-28
异动快报：汉森制药（002412）4月28日9点36分触及涨停板
图解汉森制药年报：第四季度单季净利润同比增长29.17%
证券之星 · 04-28
图解汉森制药年报：第四季度单季净利润同比增长29.17%
股市必读：汉森制药（002412）4月15日董秘有最新回复
证券之星 · 04-16
股市必读：汉森制药（002412）4月15日董秘有最新回复
股市必读：汉森制药(002412)股东户数3.13万户，较上期增加40.32%
证券之星 · 03-30
股市必读：汉森制药(002412)股东户数3.13万户，较上期增加40.32%
汉森制药：截至2026年2月27日，公司含信用账户合并股东名册的股东总数为
证券之星 · 03-27
汉森制药：截至2026年2月27日，公司含信用账户合并股东名册的股东总数为
股市必读：汉森制药（002412）3月23日收盘跌7.75%，主力净流出712.64万元
证券之星 · 03-24
股市必读：汉森制药（002412）3月23日收盘跌7.75%，主力净流出712.64万元
汉森制药：汉森健康产业园项目定位为以中药材种植、科研加工为主，集医养、休闲旅游、商业综合配套为一体的现代农业健康产业园
证券之星 · 03-06
汉森制药：汉森健康产业园项目定位为以中药材种植、科研加工为主，集医养、休闲旅游、商业综合配套为一体的现代农业健康产业园
汉森制药(002412)2月27日股东户数3.13万户，较上期增加40.32%
证券之星 · 03-04
汉森制药(002412)2月27日股东户数3.13万户，较上期增加40.32%
汉森制药：截至2026年2月27日股东总数为31288人
证券之星 · 03-03
汉森制药：截至2026年2月27日股东总数为31288人
汉森制药(002412)1月30日股东户数2.23万户，较上期减少7.65%
证券之星 · 02-26
汉森制药(002412)1月30日股东户数2.23万户，较上期减少7.65%
汉森制药：截至2026年1月30日，公司含信用账户合并股东名册的股东总数为
证券之星 · 02-24
汉森制药：截至2026年1月30日，公司含信用账户合并股东名册的股东总数为
加载更多
公司概况
公司名称：
湖南汉森制药股份有限公司
所属行业：
医药制造业
上市日期：
2010-05-25
主营业务：
湖南汉森制药股份有限公司的主营业务是中成药制剂、化学药等医用制剂的研发、生产和销售。公司的主要产品是四磨汤口服液、缩泉胶囊、银杏叶胶囊、愈伤灵胶囊、天麻醒脑胶囊、肠胃宁、利胆止痛胶囊、胃肠灵胶囊、固体口服制剂、液体口服制剂、注射剂。
发行价格：
35.80
{"stockData":{"symbol":"002412","market":"SZ","secType":"STK","nameCN":"汉森制药","latestPrice":5.72,"timestamp":1782889431000,"preClose":5.5,"halted":0,"volume":9151184,"delay":0,"changeRate":0.04,"floatShares":498000000,"shares":503000000,"eps":0.4477,"marketStatus":"已收盘","change":0.22,"latestTime":"07-01 15:00:00","open":5.51,"high":5.75,"low":5.47,"amount":51579300,"amplitude":0.0509,"askPrice":5.73,"askSize":22,"bidPrice":5.72,"bidSize":719,"shortable":0,"etf":0,"ttmEps":0.4477,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782955800000},"marketStatusCode":5,"adr":0,"adjPreClose":5.5,"symbolType":"stock","openAndCloseTimeList":[[1782869400000,1782876600000],[1782882000000,1782889200000]],"highLimit":6.05,"lowLimit":4.95,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":503200000,"isCdr":false,"pbRate":1.14,"roa":"--","peRate":12.776413,"roe":"1.6%","epsLYR":0.3937,"committee":0.087472,"marketValue":2878000000,"turnoverRate":0.0184,"status":0,"floatMarketCap":2848000000},"requestUrl":"/m/hq/s/002412","defaultTab":"news","newsList":[{"id":"2643279528","title":"6月15日汉森制药涨5.27%，东方量化成长灵活配置混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2643279528","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643279528?lang=zh_cn&edition=full","pubTime":"2026-06-15 16:45","pubTimestamp":1781513129,"startTime":"0","endTime":"0","summary":"证券之星消息，6月15日汉森制药涨5.27%，收盘报6.59元，换手率3.33%，成交量16.6万手，成交额1.08亿元。重仓汉森制药的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为东方基金的东方量化成长灵活配置混合A。东方量化成长灵活配置混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061500020223.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0039","002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640941399","title":"汉森制药（002412）披露参股公司减少注册资本暨关联交易公告，6月2日股价下跌0.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640941399","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640941399?lang=zh_cn&edition=full","pubTime":"2026-06-02 22:45","pubTimestamp":1780411518,"startTime":"0","endTime":"0","summary":"截至2026年6月2日收盘，汉森制药报收于6.85元，较前一交易日下跌0.29%，最新总市值为34.47亿元。近日，湖南汉森制药股份有限公司披露《关于参股公司减少注册资本暨关联交易的公告》。公告显示，公司于2026年6月1日召开第七届董事会第二次会议，审议通过《关于参股公司减少注册资本暨关联交易的议案》。因公司实际控制人及副董事长在三银地产任职，本次交易构成关联交易。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200047578.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0039","BK0028","002412","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638854329","title":"汉森制药（002412）披露董事会完成换届选举及高级管理人员聘任公告，5月26日股价下跌2.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638854329","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638854329?lang=zh_cn&edition=full","pubTime":"2026-05-26 22:46","pubTimestamp":1779806778,"startTime":"0","endTime":"0","summary":"截至2026年5月26日收盘，汉森制药报收于6.62元，较前一交易日下跌2.07%，最新总市值为33.31亿元。该股当日开盘6.76元，最高6.77元，最低6.57元，成交额达6831.02万元，换手率为2.06%。近日，湖南汉森制药股份有限公司披露《关于董事会完成换届选举及聘任高级管理人员、财务总监、董事会秘书、内部审计负责人、证券事务代表的公告》。公告同时披露部分董事及高管离任情况，刘正清不再担任高管职务，傅建军等不再担任董事及高管。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052600041481.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","002412","BK0039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638531380","title":"汉森制药(002412)4月30日股东户数3.23万户，较上期增加15.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638531380","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638531380?lang=zh_cn&edition=full","pubTime":"2026-05-25 17:31","pubTimestamp":1779701493,"startTime":"0","endTime":"0","summary":"证券之星消息，近日汉森制药披露，截至2026年4月30日公司股东户数为3.23万户，较3月31日增加4396.0户，增幅为15.74%。在中药行业个股中，汉森制药股东户数低于行业平均水平，截至4月30日，中药行业平均股东户数为5.39万户。从股价来看，2026年3月31日至2026年4月30日，汉森制药区间涨幅为4.8%，在此期间股东户数增加4396.0户，增幅为15.74%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500024542.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0039","002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634291094","title":"股市必读：汉森制药(002412)股东户数3.23万户，较上期增加15.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2634291094","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634291094?lang=zh_cn&edition=full","pubTime":"2026-05-11 04:09","pubTimestamp":1778443751,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，汉森制药报收于7.19元，上涨2.42%，换手率4.81%，成交量23.97万手，成交额1.71亿元。交易信息汇总资金流向5月8日主力资金净流出80.77万元；游资资金净流出603.88万元；散户资金净流入684.66万元。股本股东变化股东户数变动近日汉森制药披露，截至2026年4月30日公司股东户数为3.23万户，较3月31日增加4396.0户，增幅为15.74%。户均持股数量由上期的1.8万股减少至1.56万股，户均持股市值为10.88万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100001906.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0039","BK0239","BK0028","002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633948826","title":"汉森制药：截至2026年4月30日，公司含信用账户合并股东名册的股东总数为","url":"https://stock-news.laohu8.com/highlight/detail?id=2633948826","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633948826?lang=zh_cn&edition=full","pubTime":"2026-05-08 11:36","pubTimestamp":1778211395,"startTime":"0","endTime":"0","summary":"证券之星消息，汉森制药(002412)05月07日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至2026年4月30日公司的股东总数是多少？谢谢汉森制药回复：尊敬的投资者您好，截至2026年4月30日，公司含信用账户合并股东名册的股东总数为：32331人。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800017386.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002412","BK0028","BK0239","BK0039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632267423","title":"每周股票复盘：汉森制药（002412）股东户数降10.72%，净利增241.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632267423","media":"证券之星","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632267423?lang=zh_cn&edition=full","pubTime":"2026-05-03 03:25","pubTimestamp":1777749912,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，汉森制药报收于6.99元，较上周的6.44元上涨8.54%。本周，汉森制药4月29日盘中最高价报7.15元。本周共计1次涨停收盘，无跌停收盘情况。汉森制药当前最新总市值35.17亿元，在中药板块市值排名51/66，在两市A股市值排名4305/5200。业绩披露要点财务报告2026年一季报显示，公司主营收入2.63亿元，同比下降2.25%；归母净利润3840.64万元，同比上升241.17%；扣非净利润3608.52万元，同比上升295.83%；负债率11.36%，投资收益-1098.28万元，财务费用3.38万元，毛利率79.3%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300000672.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","002412","BK0039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631500566","title":"汉森制药：公司严格按照《企业会计准则》等有关规定，采用整个存续期的预期信用损失的金额计量减值损失","url":"https://stock-news.laohu8.com/highlight/detail?id=2631500566","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631500566?lang=zh_cn&edition=full","pubTime":"2026-04-30 15:09","pubTimestamp":1777532955,"startTime":"0","endTime":"0","summary":"证券之星消息，汉森制药(002412)04月29日在投资者关系平台上答复投资者关心的问题。投资者提问：2025年年报显示，公司应收账款占比较高，但坏账准备占总资产比例只有0.01%，请问公司是否在故意调节坏账准备？汉森制药回复：尊敬的投资者您好，公司严格按照《企业会计准则》等有关规定，采用整个存续期的预期信用损失的金额计量减值损失。不存在故意调节的行为。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000046128.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0039","BK0239","BK0028","002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631555339","title":"汉森制药（002412）2026年一季报简析：净利润同比增长241.17%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2631555339","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631555339?lang=zh_cn&edition=full","pubTime":"2026-04-29 08:51","pubTimestamp":1777423877,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期汉森制药发布2026年一季报。截至本报告期末，公司营业总收入2.63亿元，同比下降2.25%，归母净利润3840.64万元，同比上升241.17%。本报告期汉森制药盈利能力上升，毛利率同比增幅3.54%，净利率同比增幅249.02%。去年的净利率为19.07%，算上全部成本后，公司产品或服务的附加值高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900027465.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630533347","title":"异动快报：汉森制药（002412）4月28日9点36分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2630533347","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630533347?lang=zh_cn&edition=full","pubTime":"2026-04-28 09:40","pubTimestamp":1777340443,"startTime":"0","endTime":"0","summary":"证券之星4月28日盘中消息，9点36分汉森制药（002412）触及涨停板。其所属行业中药目前上涨。领涨股为汉森制药。该股为流感，中药，医药概念热股，当日流感概念上涨1.12%，中药概念上涨0.39%，医药概念上涨0.32%。4月27日的资金流向数据方面，主力资金净流入404.05万元，占总成交额6.72%，游资资金净流入95.05万元，占总成交额1.58%，散户资金净流出499.1万元，占总成交额8.3%。近5日资金流向一览见下表：汉森制药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800029846.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002412","BK0039","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630199523","title":"图解汉森制药年报：第四季度单季净利润同比增长29.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630199523","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630199523?lang=zh_cn&edition=full","pubTime":"2026-04-28 01:25","pubTimestamp":1777310733,"startTime":"0","endTime":"0","summary":"证券之星消息，汉森制药2025年年报显示，当年度公司主营收入10.39亿元，同比上升3.41%；归母净利润1.98亿元，同比下降10.05%；扣非净利润1.9亿元，同比下降10.08%；其中2025年第四季度，公司单季度主营收入2.98亿元，同比下降4.03%；单季度归母净利润1.16亿元，同比上升29.17%；单季度扣非净利润1.13亿元，同比上升27.77%；负债率11.59%，投资收益634.82万元，财务费用72.32万元，毛利率77.36%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800003945.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627115231","title":"股市必读：汉森制药（002412）4月15日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2627115231","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627115231?lang=zh_cn&edition=full","pubTime":"2026-04-16 01:32","pubTimestamp":1776274331,"startTime":"0","endTime":"0","summary":"截至2026年4月15日收盘，汉森制药报收于6.72元，上涨1.82%，换手率3.18%，成交量15.83万手，成交额1.06亿元。董秘最新回复投资者： 请问截止4月10日股东人数是多少？当日关注点来自交易信息汇总：4月15日主力资金净流入519.05万元，显示主力对个股短期关注度提升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600002182.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0039","002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623368752","title":"股市必读：汉森制药(002412)股东户数3.13万户，较上期增加40.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623368752","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623368752?lang=zh_cn&edition=full","pubTime":"2026-03-30 05:11","pubTimestamp":1774818671,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，汉森制药报收于6.55元，上涨3.48%，换手率2.05%，成交量10.21万手，成交额6582.24万元。来自股本股东变化：截至2026年2月27日股东户数环比增长40.32%，户均持股数量下降至1.61万股。交易信息汇总资金流向3月27日主力资金净流入291.07万元；游资资金净流出276.83万元；散户资金净流出14.24万元。股本股东变化股东户数变动近日汉森制药披露，截至2026年2月27日公司股东户数为3.13万户，较1月30日增加8991.0户，增幅为40.32%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000001095.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0039","002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622848722","title":"汉森制药：截至2026年2月27日，公司含信用账户合并股东名册的股东总数为","url":"https://stock-news.laohu8.com/highlight/detail?id=2622848722","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622848722?lang=zh_cn&edition=full","pubTime":"2026-03-27 15:00","pubTimestamp":1774594845,"startTime":"0","endTime":"0","summary":"证券之星消息，汉森制药(002412)03月26日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，截至2026年3月 20日公司的股东总数是多少？谢谢汉森制药回复：尊敬的投资者您好，公司可在互动易平台回复非定期报告时点的月末股东人数，截至2026年2月27日，公司含信用账户合并股东名册的股东总数为：31288人。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700026228.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","002412","BK0039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621086702","title":"股市必读：汉森制药（002412）3月23日收盘跌7.75%，主力净流出712.64万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621086702","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621086702?lang=zh_cn&edition=full","pubTime":"2026-03-24 03:00","pubTimestamp":1774292439,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，汉森制药报收于6.07元，下跌7.75%，换手率2.75%，成交量13.68万手，成交额8555.56万元。交易信息汇总股价提醒3月23日汉森制药收盘报6.07元，跌7.75%，当日成交1368.41万元。根据收盘数据统计，该股已连续3日下跌。前10个交易日资金流向情况：主力资金累计净流出1438.84万元，股价累计下跌12.62%；融资余额累计增加227.9万元，融券余量累计增加3.51万股。资金流向3月23日主力资金净流出712.64万元；游资资金净流入88.06万元；散户资金净流入624.58万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400002670.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002412","BK0028","BK0239","BK0039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617187680","title":"汉森制药：汉森健康产业园项目定位为以中药材种植、科研加工为主，集医养、休闲旅游、商业综合配套为一体的现代农业健康产业园","url":"https://stock-news.laohu8.com/highlight/detail?id=2617187680","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617187680?lang=zh_cn&edition=full","pubTime":"2026-03-06 20:51","pubTimestamp":1772801503,"startTime":"0","endTime":"0","summary":"证券之星消息，汉森制药03月05日在投资者关系平台上答复投资者关心的问题。关于中药种植及银发经济、康养相关业务方面，汉森健康产业园项目定位为以中药材种植、科研加工为主，集医养、休闲旅游、商业综合配套为一体的现代农业健康产业园，公司力求将该项目打造成中药材种植加工科研、中医药疗养、中医文化养生旅游三大产业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030600037778.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002412","BK0039","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616533540","title":"汉森制药(002412)2月27日股东户数3.13万户，较上期增加40.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616533540","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616533540?lang=zh_cn&edition=full","pubTime":"2026-03-04 17:10","pubTimestamp":1772615431,"startTime":"0","endTime":"0","summary":"证券之星消息，近日汉森制药披露，截至2026年2月27日公司股东户数为3.13万户，较1月30日增加8991.0户，增幅为40.32%。在中药行业个股中，汉森制药股东户数低于行业平均水平，截至2月27日，中药行业平均股东户数为5.26万户。从股价来看，2026年1月30日至2026年2月27日，汉森制药区间涨幅为10.24%，在此期间股东户数增加8991.0户，增幅为40.32%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030400029754.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","002412","BK0039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616395569","title":"汉森制药：截至2026年2月27日股东总数为31288人","url":"https://stock-news.laohu8.com/highlight/detail?id=2616395569","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616395569?lang=zh_cn&edition=full","pubTime":"2026-03-03 09:16","pubTimestamp":1772500578,"startTime":"0","endTime":"0","summary":"证券之星消息，汉森制药(002412)03月02日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘您好，请问公司到二月底的股东人数，谢谢汉森制药回复：尊敬的投资者您好，截至2026年2月27日，公司含信用账户合并股东名册的股东总数为：31288人。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300007670.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0039","002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614016206","title":"汉森制药(002412)1月30日股东户数2.23万户，较上期减少7.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614016206","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614016206?lang=zh_cn&edition=full","pubTime":"2026-02-26 17:16","pubTimestamp":1772097415,"startTime":"0","endTime":"0","summary":"证券之星消息，近日汉森制药披露，截至2026年1月30日公司股东户数为2.23万户，较11月28日减少1848.0户，减幅为7.65%。在中药行业个股中，汉森制药股东户数低于行业平均水平，截至1月30日，中药行业平均股东户数为5.25万户。从股价来看，2025年11月28日至2026年1月30日，汉森制药区间跌幅为1.46%，在此期间股东户数减少1848.0户，减幅为7.65%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600026073.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002412","BK0028","BK0239","BK0039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613793481","title":"汉森制药：截至2026年1月30日，公司含信用账户合并股东名册的股东总数为","url":"https://stock-news.laohu8.com/highlight/detail?id=2613793481","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613793481?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:09","pubTimestamp":1771920583,"startTime":"0","endTime":"0","summary":"证券之星消息，汉森制药(002412)02月24日在投资者关系平台上答复投资者关心的问题。投资者提问：请问最新一期公司的股东人数是多少？汉森制药回复：尊敬的投资者您好，公司可在互动易平台回复非定期报告时点的月末股东人数，截至2026年1月30日，公司含信用账户合并股东名册的股东总数为：22297人。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400028892.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002412","BK0039","BK0028"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1782911858805,"stockEarnings":[{"period":"1week","weight":-0.0879},{"period":"1month","weight":-0.1386},{"period":"3month","weight":-0.1625},{"period":"6month","weight":-0.101},{"period":"1year","weight":-0.0736},{"period":"ytd","weight":-0.101}],"compareEarnings":[{"period":"1week","weight":-0.0029},{"period":"1month","weight":0.0063},{"period":"3month","weight":0.0369},{"period":"6month","weight":0.0316},{"period":"1year","weight":0.1887},{"period":"ytd","weight":0.0316}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"湖南汉森制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"32331人(较上一季度增加15.74%)","perCapita":"15398股","listingDate":"2010-05-25","address":"湖南省益阳市赫山区银城大道2688号","registeredCapital":"50320万元","survey":" 湖南汉森制药股份有限公司的主营业务是中成药制剂、化学药等医用制剂的研发、生产和销售。公司的主要产品是四磨汤口服液、缩泉胶囊、银杏叶胶囊、愈伤灵胶囊、天麻醒脑胶囊、肠胃宁、利胆止痛胶囊、胃肠灵胶囊、固体口服制剂、液体口服制剂、注射剂。","listedPrice":35.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"汉森制药(002412)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供汉森制药(002412)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"汉森制药,002412,汉森制药股票,汉森制药股票老虎,汉森制药股票老虎国际,汉森制药行情,汉森制药股票行情,汉森制药股价,汉森制药股市,汉森制药股票价格,汉森制药股票交易,汉森制药股票购买,汉森制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"汉森制药(002412)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供汉森制药(002412)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}